Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. The transaction closed on April 30, 2022
Elon Musk References 1989 Bestseller On RJR Nabisco Leveraged Buyout; Is He Closing In On Twitter Buy?
Tesla, Inc. (NASDAQ: TSLA) CEO Elon Musk made overtures toward Twitter, Inc. (NYSE: TWTR), which expectedly was met with resistance from Twitter's board.
